Literature DB >> 19487271

Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).

Kiet Phong Tiev1, Elisabeth Diot, Pierre Clerson, Frédérique Dupuis-Siméon, Eric Hachulla, Pierre-Yves Hatron, Joël Constans, Daniéla Cirstéa, Dominique Farge-Bancel, Patrick H Carpentier.   

Abstract

OBJECTIVE: Digital ulcers are the most frequent vascular manifestations of systemic sclerosis (SSc). Clinical features of patients with prior or current digital ulcers have not been extensively described. This cross-sectional analysis of a large multicenter cohort compared the characteristics of SSc patients with prior or current digital ulcers with those never affected.
METHODS: Patients with prior/current digital ulcers or never affected were identified in the cohort of SSc patients enrolled in the French ItinérAIR-Sclérodermie registry. Rodnan skin scores, pulmonary function test results, and clinical and immunological data were analyzed to identify digital ulcerassociated clinical features.
RESULTS: Of 599 SSc patients, 317 had prior or current digital ulcers. These patients were more frequently male, with impaired diffusing capacity for carbon monoxide (DLCO), and higher Rodnan skin scores than patients never affected by digital ulcers. In a multivariate analysis, male gender, early onset of SSc, increased duration of SSc, high Rodnan skin score, and presence of anti-topoisomerase I antibodies (anti-topo I) were associated with prior or current digital ulcers. Comparison of patients with current digital ulcers versus patients never affected indicated that affected patients had increased duration of SSc, impaired DLCO, increased Rodnan score, and younger age at onset of SSc.
CONCLUSION: Male patients with early onset SSc, more severe skin fibrosis, impaired DLCO, and anti-topo I were most likely to exhibit prior or current digital ulcers. Confirmation of these results in a prospective longitudinal study may enable identification of patients at greatest risk of developing digital ulcers, facilitating management of this disabling complication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487271     DOI: 10.3899/jrheum.081044

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.

Authors:  Tanaka Ngcozana; Voon Ong; Christopher Paul Denton
Journal:  BMJ Case Rep       Date:  2014-03-28

2.  [Critical limb ischemia in systemic sclerosis].

Authors:  M O Becker; G Riemekasten
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

Review 3.  Management of Raynaud's phenomenon and digital ischemia.

Authors:  Ariane L Herrick
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

4.  Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Authors:  Jelena Blagojevic; G Abignano; J Avouac; L Cometi; M Frerix; S Bellando-Randone; S Guiducci; C Bruni; D Huscher; V K Jaeger; V Lóránd; B Maurer; S Nihtyanova; G Riemekasten; E Siegert; I H Tarner; S Vettori; U A Walker; L Czirják; C P Denton; O Distler; Y Allanore; U Müller-Ladner; A Moggi-Pignone; M Matucci-Cerinic; F Del Galdo
Journal:  Clin Rheumatol       Date:  2019-05-20       Impact factor: 2.980

5.  Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.

Authors:  Zsuzsanna H McMahan; Tricia R Cottrell; Fredrick M Wigley; Brendan Antiochos; Elias T Zambidis; Tea Soon Park; Marc K Halushka; Laura Gutierrez-Alamillo; Raffaello Cimbro; Antony Rosen; Livia Casciola-Rosen
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

Review 6.  Points to consider-Raynaud's phenomenon in systemic sclerosis.

Authors:  Maurizio Cutolo; Vanessa Smith; Daniel E Furst; Dinesh Khanna; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

7.  [Digital ulcers in systemic scleroderma].

Authors:  D Belz; N Hunzelmann; P Moinzadeh
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

8.  Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.

Authors:  Sophie Blaise; Matthieu Roustit; Alexandra Forli; Bernard Imbert; Jean-Luc Cracowski
Journal:  Int Wound J       Date:  2017-03-16       Impact factor: 3.315

Review 9.  Raynaud phenomenon and digital ulcers in systemic sclerosis.

Authors:  Michael Hughes; Yannick Allanore; Lorinda Chung; John D Pauling; Christopher P Denton; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2020-02-25       Impact factor: 20.543

Review 10.  Points to consider for skin ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Yannick Allanore; Lázló Czirjak; Daniel E Furst; Dinesh Khanna; Marco Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.